This is the protocol for a review and there is no abstract. The objectives are as follows: To compare a once-daily combination of inhaled corticosteroid and long-acting beta-agonist inhalers (ICS/LABA) versus inhaled long-acting muscarinic antagonists alone (LAMA) in people with chronic obstructive pulmonary disease (COPD).
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Sliwka, A., Jankowski, M., Gross-Sondej, I., Nowobilski, R., & Bala, M. M. (2016). Once daily Long-acting beta2-agonists/Inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2016(9). https://doi.org/10.1002/14651858.CD012355